Egypt: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2023

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Egypt

In 2021, the Egyptian market for hormones, prostaglandins, thromboxanes and leukotrienes decreased by -47.1% to $X, falling for the second consecutive year after two years of growth. Over the period under review, consumption showed a abrupt setback. Hormones, prostaglandins, thromboxanes and leukotrienes consumption peaked at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports from Egypt

In 2021, hormones, prostaglandins, thromboxanes and leukotrienes exports from Egypt declined rapidly to X kg, reducing by -19.1% compared with the previous year. Overall, exports, however, posted noticeable growth. The most prominent rate of growth was recorded in 2017 when exports increased by 142%. As a result, the exports reached the peak of X kg. From 2018 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports soared to $X in 2021. In general, exports, however, continue to indicate a significant increase. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

Nigeria (X kg) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from Egypt, accounting for a 70% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to Nigeria exceeded the volume sent to the second major destination, France (X kg), threefold. The third position in this ranking was taken by Kenya (X kg), with a 2.1% share.

From 2012 to 2021, the average annual growth rate of volume to Nigeria stood at +15.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (0.0% per year) and Kenya (-60.8% per year).

In value terms, France ($X) emerged as the key foreign market for hormones, prostaglandins, thromboxanes and leukotrienes exports from Egypt, comprising 44% of total exports. The second position in the ranking was held by Kenya ($X), with a 0.8% share of total exports. It was followed by Nigeria, with a 0.3% share.

From 2012 to 2021, the average annual rate of growth in terms of value to France amounted to +77.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Kenya (-35.8% per year) and Nigeria (-32.8% per year).

Export Prices by Country

The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per ton in 2021, surging by 1,700% against the previous year. Overall, the export price showed a strong increase. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably country of destination: the country with the highest price was France ($X per ton), while the average price for exports to Nigeria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Kenya (+62.5%), while the prices for the other major destinations experienced a decline.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports into Egypt

In 2021, overseas purchases of hormones, prostaglandins, thromboxanes and leukotrienes decreased by -50.3% to X tons, falling for the second year in a row after two years of growth. Over the period under review, imports saw a deep reduction. The pace of growth was the most pronounced in 2019 when imports increased by 74%. As a result, imports reached the peak of X tons. From 2020 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports declined markedly to $X in 2021. Overall, imports recorded a abrupt slump. The most prominent rate of growth was recorded in 2018 with an increase of 53%. Over the period under review, imports attained the peak figure at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

Imports by Country

China (X tons), Germany (X tons) and India (X tons) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to Egypt, with a combined 65% share of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by India (with a CAGR of +16.3%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), India ($X) and Italy ($X) constituted the largest hormones, prostaglandins, thromboxanes and leukotrienes suppliers to Egypt, together comprising 49% of total imports.

Among the main suppliers, India, with a CAGR of +18.0%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, rising by 12% against the previous year. Overall, the import price, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2018 when the average import price increased by 45% against the previous year. As a result, import price attained the peak level of $X per kg. From 2019 to 2021, the average import prices failed to regain momentum.

Prices varied noticeably country of origin: the country with the highest price was Switzerland ($X per kg), while the price for Germany ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Switzerland (+45.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :